back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2020-02-06 18:04 Tx date 2020-02-03 |
$RQB
RavenQuest BioMed Inc. |
ROBINSON, GEORGE
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
47 - Acquisition or disposition by gift
|
-1,000,000 vol |
6,580,000 | |
| Filed 2019-10-30 16:20 Tx date 2019-10-30 |
$RQB
RavenQuest BioMed Inc. |
Ahrens-Townsend, Mark William
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-10-30 16:19 Tx date 2019-10-30 |
$RQB
RavenQuest BioMed Inc. |
Ahrens-Townsend, Mark William
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-10-30 16:19 Tx date 2019-10-30 |
$RQB
RavenQuest BioMed Inc. |
Ahrens-Townsend, Mark William
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
165,000 | ||
| Filed 2019-03-25 Tx date 2019-03-15 |
$RQB
RavenQuest BioMed Inc. |
Bechtel, Chris
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$140,000
+175,000 vol $0.80 each |
175,000 | |
| Filed 2019-03-25 Tx date 2019-03-15 |
$RQB
RavenQuest BioMed Inc. |
Bechtel, Chris
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$210,000
+350,000 vol $0.60 each |
1,800,000 | |
| Filed 2018-10-10 Tx date 2018-10-09 |
$RQB
RavenQuest BioMed Inc. |
Bechtel, Chris
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-261,500
-250,000 vol $1.05 each |
1,450,000 | |
| Filed 2018-07-18 Tx date 2018-07-18 |
$RQB
RavenQuest BioMed Inc. |
ROBINSON, GEORGE
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,600
+20,000 vol $0.53 each |
7,580,000 | |
| Filed 2018-05-30 Tx date 2018-05-22 |
$RQB
RavenQuest BioMed Inc. |
Bechtel, Chris
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-191,317.50
-225,000 vol $0.85 each |
1,700,000 | |
| Filed 2018-05-30 Tx date 2018-05-18 |
$RQB
RavenQuest BioMed Inc. |
Bechtel, Chris
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-21,500
-25,000 vol $0.86 each |
1,925,000 | |
| Filed 2017-10-31 Tx date 2017-10-25 |
$RQB
RavenQuest Biomed Inc. |
BONET, JORGE
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$312,500
+250,000 vol $1.25 each |
||
| Filed 2017-10-31 Tx date 2017-10-25 |
$RQB
RavenQuest Biomed Inc. |
BONET, JORGE
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$312,500
+250,000 vol $1.25 each |
250,000 | |
| Filed 2017-10-31 Tx date 2017-10-26 |
$RQB
RavenQuest Biomed Inc. |
Bechtel, Chris
4 - Director of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$20,000
+400,000 vol $0.05 each |
1,950,000 | |
| Filed 2017-10-31 Tx date 2017-10-26 |
$RQB
RavenQuest Biomed Inc. |
Bechtel, Chris
4 - Director of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-20,000
-400,000 vol $0.05 each |
0 | |
| Filed 2017-10-30 Tx date 2017-09-28 |
$RQB
RavenQuest Biomed Inc. |
ROBINSON, GEORGE
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-10-30 Tx date 2017-09-28 |
$RQB
RavenQuest Biomed Inc. |
Cross, David Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-10-30 Tx date 2017-09-06 |
$RQB
RavenQuest Biomed Inc. |
Bechtel, Chris
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-10-30 Tx date 2017-10-25 |
$RQB
RavenQuest Biomed Inc. |
Bechtel, Chris
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$312,500
+250,000 vol $1.25 each |
250,000 | |
| Filed 2017-10-30 Tx date 2017-09-06 |
$RQB
RavenQuest Biomed Inc. |
BONET, JORGE
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-10-30 Tx date 2017-10-25 |
$RQB
RavenQuest Biomed Inc. |
BONET, JORGE
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$312,500
+250,000 vol $1.25 each |
250,000 |